Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean region.

[1]  M. Alford.  Tipificación del Virus del Papiloma Humano en Papilomatosis Laríngea Recurrente Juvenil , 2001 .

[2]  M. Jiménez-Pérez,et al.  Has the use of pap smears reduced the risk of invasive cervical cancer in Guadalajara, Mexico? , 1999, International journal of cancer.

[3]  E. Gómez.  Gender, women, and health in the Americas , 1995 .

[4]  F. Bray,et al.  Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost , 2004, International journal of cancer.

[5]  F Berrino,et al.  EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  N. Muñoz,et al.  Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. , 2007, The Lancet. Infectious diseases.

[7]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[8]  Daron G Ferris,et al.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. , 2007, The New England journal of medicine.

[9]  K. Holmes,et al.  Reproductive tract infections in rural women from the highlands, jungle, and coastal regions of Peru. , 2004, Bulletin of the World Health Organization.

[10]  S. Franceschi,et al.  Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[11]  J. H. Pearson.  Cervical cancer screening programs. , 1983, Canadian Medical Association journal.

[12]  J. Ferlay,et al.  Cancer incidence estimates at the national and district levels in Colombia. , 2006, Salud publica de Mexico.

[13]  Alan D. Lopez,et al.  Counting the dead and what they died from: an assessment of the global status of cause of death data. , 2005, Bulletin of the World Health Organization.

[14]  L. Villa,et al.  Low frequency of p53 mutations in cervical carcinomas among Brazilian women. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[15]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[16]  P. Porter,et al.  Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer , 2004, Cancer.

[17]  N. Muñoz,et al.  Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus‐like‐particle vaccine in Latin American women , 2008, International journal of cancer.

[18]  Martyn Plummer,et al.  International Correlation between Human Papillomavirus Prevalence and Cervical Cancer Incidence , 2008, Cancer Epidemiology Biomarkers & Prevention.

[19]  Silvina Arrossi,et al.  Incidence and mortality of cervical cancer in Latin America. , 2003, Salud publica de Mexico.

[20]  F. X. Bosch,et al.  Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. , 2008, Vaccine.

[21]  E. Lazcano-Ponce,et al.  Prognostic factors related to cervical cancer survival in Mexican women , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[22]  H. Torloni,et al.  Human papillomavirus DNA in respiratory papillomatosis detected by in situ hybridization and the polymerase chain reaction. , 1989, The American journal of pathology.

[23]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[24]  P. Correa,et al.  The impact of vaginal cytology on cervical cancer risks in cali, Colombia , 1984, International journal of cancer.

[25]  Anthony M. A. Smith,et al.  Sex in Australia: Sexually transmissible infection and blood‐borne virus history in a representative sample of adults , 2003, Australian and New Zealand journal of public health.

[26]  K. Shah,et al.  HPV prevalence among Mexican women with neoplastic and normal cervixes. , 1998, Gynecologic oncology.

[27]  N. Muñoz,et al.  Prevalence of Human Papillomavirus Infection Among Women in Concordia, Argentina:: A Population-Based Study , 2003, Sexually transmitted diseases.

[28]  M. J. van de Vijver,et al.  Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. , 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[29]  C. la Vecchia,et al.  Trends in cancer mortality in the Americas, 1970-2000. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  S. Flores-Martínez,et al.  Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis. , 2000, Archives of otolaryngology--head & neck surgery.

[31]  S. Wacholder,et al.  Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. , 2005, The Journal of infectious diseases.

[32]  E. Dasbach,et al.  The health and economic burden of genital warts in a set of private health plans in the United States. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  R. Sankaranarayanan,et al.  Trends in survival rates of cancer in Cuba , 1999, European Journal of Epidemiology.

[34]  T. Romero,et al.  Evaluation of the cervical cancer control program in Cuba. , 1996, Bulletin of the Pan American Health Organization.

[35]  C. Wheeler,et al.  New technologies in cervical cancer screening. , 2008, Vaccine.

[36]  S. Tatti,et al.  Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. , 2005, Anticancer research.

[37]  Human papillomavirus–specific viral types are common in Mexican women affected by cervical lesions , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[38]  C. Antunes,et al.  Sexually transmitted diseases in homosexual and bisexual males from a cohort of human immunodeficiency virus negative volunteers (Project Horizonte), Belo Horizonte, Brazil. , 2000, Memorias do Instituto Oswaldo Cruz.

[39]  S. Feig.  IARC Handbooks of Cancer Prevention , 2003 .

[40]  C. Cuvelier,et al.  Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix , 2006, Sexually Transmitted Infections.

[41]  R. Drut,et al.  Detection of human papillomavirus in juvenile laryngeal papillomatosis using polymerase chain reaction. , 1995, Medicina.

[42]  L. Zuloaga Posada,et al.  Sexual behavior and health problems in university students, University of Antioquia, 1991. , 1995, Bulletin of the Pan American Health Organization.

[43]  R. Hayes,et al.  Tobacco and alcohol use and oral cancer in Puerto Rico , 1999, Cancer Causes & Control.

[44]  Epidemiología de la infección cervical por virus Papiloma humano en Ushuaia, Argentina , 2006 .

[45]  C. Lacey.  Therapy for genital human papillomavirus-related disease. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[46]  C. la Vecchia,et al.  Trends in uterine cancer mortality in the Americas, 1955-1988. , 1993, Gynecologic oncology.

[47]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[48]  J. Silvi.  On the estimation of mortality rates for countries of the Americas. , 2003, Epidemiological bulletin.

[49]  A. Ferrera,et al.  Chlamydia trachomatis and genital human papillomavirus infections in female university students in Honduras. , 2005, The American journal of tropical medicine and hygiene.

[50]  A. Giuliano,et al.  Human papillomavirus prevalence at the USA–Mexico border among women 40 years of age and older , 2005, International journal of STD & AIDS.

[51]  A. Teyssié,et al.  Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma. , 1999, Infectious diseases in obstetrics and gynecology.

[52]  D M Parkin,et al.  Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. , 2004, European journal of cancer.

[53]  N. Muñoz,et al.  Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. , 2008, Vaccine.

[54]  K. Jørgensen.  [Cervix cancer screening]. , 2008, Ugeskrift for laeger.

[55]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .

[56]  D. Spiegelman,et al.  Human immunodeficiency virus infection in Mexico City. Rectal bleeding and anal warts as risk factors among men reporting sex with men. , 1996, American journal of epidemiology.

[57]  Anne M Johnson,et al.  Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection , 2001, The Lancet.

[58]  A. Meneses,et al.  Utilidad en la combinación de oligonucleótidos universales para la detección del virus del papiloma humano en cáncer cervicouterino y lesiones premalignas , 2004 .

[59]  V. Moreno,et al.  International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas , 1998, International journal of cancer.

[60]  S. Franceschi,et al.  Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. , 2006, Vaccine.

[61]  F. Bray,et al.  Predicting the future burden of cancer , 2006, Nature Reviews Cancer.

[62]  A. Peruga,et al.  Trends in cervical cancer mortality in the Americas. , 1996, Bulletin of the Pan American Health Organization.

[63]  Xavier Castellsagué,et al.  Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.

[64]  M. Abba,et al.  Distribución de los genotipos del virus papiloma humano en infecciones cevicales en mujeres de La Plata, Argentina , 2003 .

[65]  E. Lazcano-Ponce,et al.  Cervical cancer screening programs in Latin America and the Caribbean. , 2008, Vaccine.

[66]  F. Bray,et al.  Increasing mortality rates of common malignancies in Colombia , 2004, Cancer.